SIRT3 and prostate carcinoma: SIRT3 expression has been reported to be decreased in prostate cancer by two studies: Quan et al. [92] found that SIRT3 is moderately downregulated in prostate carcinoma tissues and Li et al. [93] detected a decrease in metastatic tissues compared to prostate tumor tissues.